LOS ANGELES--(BUSINESS WIRE)--Ocean Grown Ventures (the “Company”), a science-focused cannabis company offering wellness solutions that meet pharmaceutical manufacturing standards, today announced the appointment of Wayne Nasby as chief operating officer.
Mr. Nasby is considered an industry expert in pharmaceutical manufacturing, quality management systems and regulatory compliance for the biotech, regulated cannabis and pharmaceutical industries, having designed and built numerous state-of-the-art manufacturing plants approved by the Food and Drug Administration (“FDA”). In addition, he is an FDA U.S. Agent representative for international pharmaceutical companies.
“We are truly fortunate to have Mr. Nasby join our executive team,” said Jerry Katz, founder and chief executive officer of Ocean Grown Ventures. “His more than 30 years of regulatory and pharmaceutical experience is critical in ensuring we meet the highest possible operational standards, including stringent current good manufacturing practices (cGMP).”
Prior to joining the Company, Mr. Nasby was a board member and chief operating officer of CURE Pharmaceuticals. He is also the founder and chief executive officer of Global Compliance Specialty Group, helping manufacturers and distributors implement Quality Management Systems and Good Manufacturing Practices.
“I am thrilled to be joining Ocean Grown Ventures and am committed to its vision of improving the quality and standard of full-spectrum hemp-based CBD and THC products on the market today,” said Mr. Nasby. “By applying a pharmaceutical mentality to legal cannabis, the company is seeking to take the guesswork out of alternative wellness treatments. I am proud to be a part of this endeavor.”
About Ocean Grown Ventures
Ocean Grown Ventures (the “Company”) offers the highest quality cannabis-derived wellness solutions to the U.S. market and beyond by meeting standards usually reserved for pharmaceutical companies. Through its exclusive partnership with renowned Israeli pharmaceutical pioneer Panaxia Pharmaceutical Industries, Ocean Grown Ventures has sales and distribution rights to consistent and proprietary formulations that meet current Good Manufacturing Practices (GMP) standards. The Company applies Panaxia’s world-class scientific expertise to develop and market formulations that offer customized and accessible solutions. These are currently available via the Company’s product line ‘Tikva by Panaxia Pharmaceuticals’. Ocean Grown Ventures is headquartered in Los Angeles, California. For more information, or to inquire about white-label opportunities, please visit OceanGrownVentures.com.